Diagnosing pre-clinical dementia : the NZ Genetic Frontotemporal Dementia Study (FTDGeNZ)

Introduces and describes the NZ Genetic Frontotemporal Dementia Study (FTDGeNZ), a multidisciplinary, inter-institutional initiative in search of pre-clinical diagnostic markers of dementia in a large New Zealand kindred which carries a genetic mutation in the MAPT gene that predictably causes behav...

Full description

Saved in:
Bibliographic Details
Published inNew Zealand medical journal Vol. 131; no. 1476; pp. 88 - 91
Main Author Ryan, Brigid
Format Journal Article
LanguageEnglish
Published New Zealand Pasifika Medical Association Group (PMAG) 08.06.2018
Subjects
Alzheimer's disease
Apoptosis
Biomarkers
Brain research
Caregivers
Dementia
Disease susceptibility
Frontotemporal dementia
Genetic aspects
Genetic markers
Medical diagnosis
Medical imaging
Mutation
Neurology
Proteins
Researchers
Semantics
New Zealand
Online AccessGet full text

Cover

More Information
Summary:Introduces and describes the NZ Genetic Frontotemporal Dementia Study (FTDGeNZ), a multidisciplinary, inter-institutional initiative in search of pre-clinical diagnostic markers of dementia in a large New Zealand kindred which carries a genetic mutation in the MAPT gene that predictably causes behavioural variant frontotemporal dementia (bvFTD). Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
Bibliography:Archived by the National Library of New Zealand.
Includes references
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0028-8446
1175-8716
1175-8716